Vitalhub Corp sees modest gains as it expands AI capabilities and reports strong revenue growth.
This week, Vitalhub Corp (VHI.TO) saw a slight increase in its stock price, reflecting growing interest in its recent developments. The company made headlines with the announcement of its new AI Scribe solution and impressive revenue growth figures for the past fiscal year.
Advertisement
Vitalhub Corp
VHI.TO
VHI.TO
Vitalhub Corp
WealthAwesomeMarket cap
$477.58M
P/E
62.8x
52W high
$11.80
52W low
$6.46
1W change
+3.12%
Beta
0.86
Analyst Price Targets
Based on analyst covering VHI · as of Sep 17, 2026
Wall Street analysts forecast VHI stock price to rise 62.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$12.39
+62.8% Upside
Current Price
C$7.61
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on VHI's historical volatility
30-Day Vol
43.8%
Annualized
90-Day Vol
41.6%
Annualized
Trend (90d)
+24.4%
Annualized drift
90d Mean
C$8.30
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$7.83 | C$6.73 – C$9.11 |
| 60 trading days | C$8.07 | C$6.51 – C$9.99 |
| 90 trading days | C$8.30 | C$6.39 – C$10.79 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may find Vitalhub's growth trajectory and AI advancements noteworthy as the company continues to position itself in the health tech sector. However, the stock's performance this year has been mixed, with significant volatility.
Vitalhub Reports 59% Increase in Annual Recurring Revenue
The company reported a 59% year-over-year increase in Annual Recurring Revenue, reaching $71.1 million, indicating strong demand for its services amid competitive pressures in the health tech industry.
Bull case
The new AI Scribe could help healthcare professionals streamline their operations, potentially boosting demand for Vitalhub's solutions. Along with the significant increase in annual recurring revenue, these factors may lead to a more optimistic outlook for the company.
Bear case
Despite recent gains, the stock has struggled this year, and its high P/E ratio might indicate overvaluation. Investors should be cautious about market volatility and the company's ability to maintain growth.
Recent Price Action
Advertisement
Vitalhub Corp's stock closed at C$7.61 on Thursday, reflecting a gain of 0.93% for the day. Over the past week, the stock has appreciated by 3.12%, showing positive sentiment among investors. However, it remains down 20.23% year-to-date, highlighting some challenges faced earlier in the year.
Company Developments
This week, Vitalhub announced its AI Scribe, a new ambient clinical intelligence solution designed to assist healthcare professionals by capturing conversations and generating documentation. This innovation aims to reduce administrative burdens, potentially improving productivity in clinical settings. Additionally, the company reported a 59% increase in Annual Recurring Revenue, reaching $71.1 million, along with a 51% increase in total revenue to $20.6 million for the year ending December 31, 2024.
Technical Picture
Analyzing the technical indicators, Vitalhub's stock is currently trading above its 50-day moving average of C$7.55, suggesting a short-term bullish trend. However, it is trading below its 200-day moving average of C$7.86, indicating potential long-term challenges. The stock has a 52-week range of C$6.46 to C$11.80, with its current price at approximately 22% of that range. The stock has a beta of 0.86, suggesting it is less volatile than the broader market. Recent trading volume of 205,892 shares is notably higher than the 20-day average volume of 168,966 shares, indicating increased investor interest.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
